|
|
|
Volumn 92, Issue 11, 2017, Pages 117-128
|
|
Recommended composition of influenza virus vaccines for use in the 2017–2018 northern hemisphere influenza season
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
ENZYME INHIBITOR;
INFLUENZA VACCINE;
SIALIDASE;
VIRUS ANTIBODY;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
BLOOD;
DRUG EFFECTS;
GENETICS;
HEALTH;
HUMAN;
IMMUNOLOGY;
INFLUENZA A VIRUS (H1N1);
INFLUENZA A VIRUS (H3N2);
INFLUENZA B VIRUS;
INFLUENZA, HUMAN;
MEDICAL GEOGRAPHY;
SEASON;
STATISTICS AND NUMERICAL DATA;
VIROLOGY;
ZOONOSES;
ANIMALS;
ANTIBODIES, VIRAL;
ANTIVIRAL AGENTS;
ENZYME INHIBITORS;
GEOGRAPHY, MEDICAL;
GLOBAL HEALTH;
HUMANS;
INFLUENZA A VIRUS, H1N1 SUBTYPE;
INFLUENZA A VIRUS, H3N2 SUBTYPE;
INFLUENZA B VIRUS;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
NEURAMINIDASE;
SEASONS;
ZOONOSES;
|
|
EID: 85015597289
PISSN: 00498114
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (31)
|
|
References (0)
|